Unpacking the Latest Options Trading Trends in Eli Lilly and Co
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
Financial giants have made a conspicuous bullish move on Eli Lilly and Co. Our analysis of options history for Eli Lilly and Co (NYSE:LLY) revealed 56 unusual trades.
金融巨頭對禮來股票採取了顯著的看好舉動。我們對Eli Lilly and Co (NYSE:LLY)的期權歷史進行了分析，發現有56筆飛凡的交易。
Delving into the details, we found 41% of traders were bullish, while 35% showed bearish tendencies. Out of all the trades we spotted, 10 were puts, with a value of $1,737,333, and 46 were calls, valued at $3,169,813.
進一步了解後，我們發現41%的交易員看好，而35%的交易員表現出了看淡的趨勢。我們發現了10個看跌期權交易，價值爲1,737,333美元，還有46個看漲期權交易，價值爲3,169,813美元。
Projected Price Targets
預計價格目標
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $300.0 and $1100.0 for Eli Lilly and Co, spanning the last three months.
通過評估成交量和未平倉量，顯然市場主要交易者正在關注Eli Lilly and Co在目標價區間（$300.0至$1100.0）內的表現，區間跨越了最近三個月。
Analyzing Volume & Open Interest
分析成交量和未平倉合約
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
這些數據可以幫助您跟蹤Coinbase Glb期權的流動性和利益，以給定的行權價格爲基礎。
This data can help you track the liquidity and interest for Eli Lilly and Co's options for a given strike price.
這些數據可以幫助您追蹤禮來股票在給定行權價格的期權的流動性和利益。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly and Co's whale activity within a strike price range from $300.0 to $1100.0 in the last 30 days.
以下是過去30天禮來公司所有的鯨魚活動中，行權價格在$300.0至$1100.0區間內看漲期權和看跌期權的成交量和未平倉量的演變。
Eli Lilly and Co Option Activity Analysis: Last 30 Days
禮來 期權活動分析：過去30天
Significant Options Trades Detected:
檢測到重大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | PUT | TRADE | BULLISH | 11/15/24 | $77.25 | $76.1 | $76.1 | $960.00 | $1.1M | 0 | 0 |
| LLY | CALL | TRADE | BEARISH | 01/16/26 | $202.9 | $199.05 | $199.05 | $860.00 | $199.0K | 55 | 0 |
| LLY | CALL | SWEEP | BULLISH | 01/17/25 | $63.6 | $61.4 | $62.72 | $1000.00 | $157.5K | 2.0K | 2 |
| LLY | CALL | TRADE | BULLISH | 01/17/25 | $63.55 | $61.45 | $62.83 | $1000.00 | $157.0K | 2.0K | 2 |
| LLY | CALL | TRADE | NEUTRAL | 01/17/25 | $63.4 | $60.75 | $61.86 | $1000.00 | $154.6K | 2.0K | 111 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | 看跌 | 交易 | 看好 | 11/15/24 | $77.25 | $76.1 | $76.1 | $960.00 | $1.1M | 0 | 0 |
| LLY | 看漲 | 交易 | 看淡 | 01/16/26 | $202.9 | $199.05 | $199.05 | $860.00 | $199.0K | 55 | 0 |
| LLY | 看漲 | SWEEP | 看好 | 01/17/25 | 63.6美元 | $61.4 | $62.72 | $1000.00 | $157.5K | 2.0K | 2 |
| LLY | 看漲 | 交易 | 看好 | 01/17/25 | $63.55 | $61.45 | $62.83 | $1000.00 | $157.0K | 2.0K | 2 |
| LLY | 看漲 | 交易 | 中立 | 01/17/25 | $63.4 | $60.75 | $61.86 | $1000.00 | $154.6K | 2.0K | 111 |
About Eli Lilly and Co
關於禮來
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
禮來是一家專注於神經科學、心臟代謝、癌症和免疫學的製藥公司。禮來的主要產品包括用於癌症的維津尼奧；馬天尼羅、澤普邦、賈達信、特魯利康、胰島素諾和人用胰島素用於糖尿病；以及用於免疫學的塔吉特和優泰樂。
Eli Lilly and Co's Current Market Status
禮來當前的市場狀態幣
- Currently trading with a volume of 915,725, the LLY's price is up by 0.76%, now at $924.94.
- RSI readings suggest the stock is currently may be overbought.
- Anticipated earnings release is in 28 days.
- 目前交易量爲915,725股，LLY的價格上漲0.76%，報924.94美元。
- RSI讀數表明股票目前可能超買。
- 預期業績發佈在28天后。
Professional Analyst Ratings for Eli Lilly and Co
禮來的專業分析師評級
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $911.0.
過去30天中，一共有5位專業分析師對這隻股票發表了評論，平均目標價爲911.0美元。
- An analyst from Jefferies persists with their Buy rating on Eli Lilly and Co, maintaining a target price of $1015.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $885.
- An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $885.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $885.
- Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $885.
- Jefferies的一位分析師持續對禮來進行買入評級，維持目標價爲1015美元。
- Cantor Fitzgerald的一位分析師採取謹慎的步態，將評級下調至輕倉，設定價格目標爲885美元。
- Cantor Fitzgerald的一位分析師已經將其評級下調爲超配，將目標價調整爲885美元。
- Cantor Fitzgerald的一位分析師將其評級下調爲超配，目標價爲885美元。
- 反映擔憂，Cantor Fitzgerald的一位分析師將評級調降至輕倉，並設定新的價格目標爲885美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期權與僅交易股票相比是一種更具風險的資產，但它們具有更高的利潤潛力。認真的期權交易者通過每日學習，進出交易，跟隨多個指標並密切關注市場來管理這種風險。